Just for the record, we no longer own CardioCel and a big group I.e LeMaitre did their due diligence and bought it from us for a good price. There were some early issues around the use of patches on high pressure grafts and that’s why the 3D aortic arch was developed.
https://marketexclusive.com/lemaitre-vascular-inc-nasdaqlmat-files-an-8-k-entry-into-a-material-definitive-agreement-2/2019/10/
Aortic Vale publications form Berlin and Munich Hospitals, page-30
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.31 |
Change
-0.090(0.87%) |
Mkt cap ! $219.8M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $121.2K | 11.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1232 | $10.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3964 | 4 |
View Market Depth
| Last trade - 13.17pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |